Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

232 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Advances in theranostic biomarkers for tumor immunotherapy.
Bellesoeur A, Torossian N, Amigorena S, Romano E. Bellesoeur A, et al. Among authors: amigorena s. Curr Opin Chem Biol. 2020 Jun;56:79-90. doi: 10.1016/j.cbpa.2020.02.005. Epub 2020 Mar 24. Curr Opin Chem Biol. 2020. PMID: 32217357 Review.
Cold Tumors: A Therapeutic Challenge for Immunotherapy.
Bonaventura P, Shekarian T, Alcazer V, Valladeau-Guilemond J, Valsesia-Wittmann S, Amigorena S, Caux C, Depil S. Bonaventura P, et al. Among authors: amigorena s. Front Immunol. 2019 Feb 8;10:168. doi: 10.3389/fimmu.2019.00168. eCollection 2019. Front Immunol. 2019. PMID: 30800125 Free PMC article. Review.
Lipid-Associated Macrophages Are Induced by Cancer-Associated Fibroblasts and Mediate Immune Suppression in Breast Cancer.
Timperi E, Gueguen P, Molgora M, Magagna I, Kieffer Y, Lopez-Lastra S, Sirven P, Baudrin LG, Baulande S, Nicolas A, Champenois G, Meseure D, Vincent-Salomon A, Tardivon A, Laas E, Soumelis V, Colonna M, Mechta-Grigoriou F, Amigorena S, Romano E. Timperi E, et al. Among authors: amigorena s. Cancer Res. 2022 Sep 16;82(18):3291-3306. doi: 10.1158/0008-5472.CAN-22-1427. Cancer Res. 2022. PMID: 35862581
Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trial.
Rodrigues M, Vanoni G, Loap P, Dubot C, Timperi E, Minsat M, Bazire L, Durdux C, Fourchotte V, Laas E, Pouget N, Castel-Ajgal Z, Marret G, Lesage L, Meseure D, Vincent-Salomon A, Lecompte L, Servant N, Vacher S, Bieche I, Malhaire C, Huchet V, Champion L, Kamal M, Amigorena S, Lantz O, Chevrier M, Romano E. Rodrigues M, et al. Among authors: amigorena s. Nat Commun. 2023 Jun 22;14(1):3698. doi: 10.1038/s41467-023-39383-8. Nat Commun. 2023. PMID: 37349318 Free PMC article. Clinical Trial.
Epigenetics of T cell fate decision.
Pace L, Amigorena S. Pace L, et al. Among authors: amigorena s. Curr Opin Immunol. 2020 Apr;63:43-50. doi: 10.1016/j.coi.2020.01.002. Epub 2020 Feb 15. Curr Opin Immunol. 2020. PMID: 32066083 Review.
232 results